NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
-4.07%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$996M
AUM Growth
+$996M
(-2.4%)
Cap. Flow
+$58.7M
Cap. Flow
% of AUM
5.9%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
137
New
19
Increased
25
Reduced
38
Closed
13
Top Buys
| 1 |
Soleno Therapeutics
SLNO
|
$27.4M |
| 2 |
Establishment Labs
ESTA
|
$24.9M |
| 3 |
Peloton Interactive
PTON
|
$15.6M |
| 4 |
Savara
SVRA
|
$13.9M |
| 5 |
The Bancorp
TBBK
|
$12.8M |
Top Sells
| 1 |
Pathward Financial
CASH
|
$27.2M |
| 2 |
Lyra Therapeutics
LYRA
|
$17.5M |
| 3 |
Red Violet
RDVT
|
$16.9M |
| 4 |
Dyne Therapeutics
DYN
|
$12.4M |
| 5 |
Golden Entertainment
GDEN
|
$9.92M |
Sector Composition
| 1 | Healthcare | 68.09% |
| 2 | Consumer Discretionary | 12.03% |
| 3 | Financials | 6.24% |
| 4 | Communication Services | 6.07% |
| 5 | Technology | 3.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Eli Lilly
LLY
$657B
| – | – | 0 | – | – |
|
127
Grand Canyon Education
LOPE
$5.66B
| – | – | 0 | – | – |
|
|
128
Lyra Therapeutics
LYRA
$11.5M
| – | – | -2,820,982 | Closed | -$17.5M |
|
129
NewAmsterdam Pharma
NAMS
$2.71B
| – | – | -175,000 | Closed | -$4.14M |
|
130
Children's Place
PLCE
$112M
| – | – | -100,000 | Closed | -$1.15M |
|
131
Tarsus Pharmaceuticals
TARS
$2.47B
| – | – | -150,321 | Closed | -$5.46M |
|
|
HURA
132
TuHURA Biosciences, Inc. Common Stock
HURA
$135M
| – | – | -12,763 | Closed | -$1.29K |
|
|
MTTR
133
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| – | – | -548,376 | Closed | -$1.24M |
|
|
GMDA
134
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| – | – | -800,000 | Closed | -$28.9K |
|
|
AGS
135
DELISTED
PlayAGS
AGS
| – | – | -566,588 | Closed | -$5.09M |
|